MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Book Value 2011-2026 | IART
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.55 B | 1.59 B | 1.8 B | 1.68 B | 1.51 B | 1.42 B | 1.38 B | 962 M | 840 M | 751 M | 704 M | 670 M | 518 M | 493 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 493 M | 1.13 B |
Quarterly Book Value Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.04 B | 1.52 B | 1.52 B | 1.53 B | 1.6 B | 1.58 B | 1.68 B | 1.67 B | 1.8 B | 1.72 B | - | 1.62 B | 1.68 B | 1.63 B | 1.57 B | 1.53 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.42 B | 1.42 B | 1.42 B | 1.42 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 962 M | 962 M | 962 M | 962 M | 840 M | 840 M | 840 M | 840 M | 751 M | 751 M | 751 M | 751 M | 704 M | 704 M | 704 M | 704 M | 666 M | 666 M | 666 M | 666 M | 518 M | 518 M | 518 M | 518 M | 493 M | 493 M | 493 M | 493 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 493 M | 1.1 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
1.53 B | $ 13.02 | 1.72 % | $ 1.76 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.62 | -2.1 % | $ 38.6 M | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
50.1 M | $ 3.24 | 0.47 % | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 11.1 | -5.77 % | $ 314 M | USA |
 |
Globus Medical
GMED
|
4.57 B | $ 93.97 | -0.96 % | $ 12.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.13 | -1.16 % | $ 1.29 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
43.2 M | $ 26.2 | -0.72 % | $ 221 M | USA |
 |
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
GBS
GBS
|
2.81 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LivaNova PLC
LIVN
|
1.2 B | $ 63.24 | -1.5 % | $ 3.45 B |  Britain |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
LENSAR
LNSR
|
-12.2 M | $ 5.15 | 1.18 % | $ 61.6 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
54.1 M | $ 1.26 | -0.39 % | $ 51.3 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 15.88 | -1.91 % | $ 373 M | USA |
 |
Butterfly Network
BFLY
|
169 M | $ 5.58 | 4.59 % | $ 1.18 B | USA |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
Insulet Corporation
PODD
|
1.52 B | $ 187.73 | -0.97 % | $ 13.2 B | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 10.82 | -0.18 % | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 38.44 | 0.16 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
781 M | $ 54.68 | -2.83 % | $ 1.61 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 84.01 | -2.32 % | $ 2.92 B | USA |
 |
PAVmed
PAVM
|
22.3 M | $ 8.32 | -7.56 % | $ 5.58 M | USA |
 |
Sintx Technologies
SINT
|
2.93 M | $ 2.41 | -2.43 % | $ 6.68 M | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.3 B | $ 84.41 | 0.19 % | $ 49.4 B | USA |
 |
Stryker Corporation
SYK
|
22.4 B | $ 329.17 | 0.51 % | $ 126 B | USA |
 |
MiMedx Group
MDXG
|
257 M | $ 3.36 | -2.19 % | $ 497 M | USA |
 |
Tactile Systems Technology
TCMD
|
219 M | $ 24.4 | -2.67 % | $ 558 M | USA |
 |
Nevro Corp.
NVRO
|
231 M | - | - | $ 217 M | USA |